Allmed Solutions Ltd
TASE:ALMD
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
30
46.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches ILS.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ALMD stock under the Base Case scenario is 53.19 ILS. Compared to the current market price of 33.2 ILS, Allmed Solutions Ltd is Undervalued by 38%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Allmed Solutions Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ALMD cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Allmed Solutions Ltd
Balance Sheet Decomposition
Allmed Solutions Ltd
Current Assets | 57.8m |
Cash & Short-Term Investments | 57.1m |
Receivables | 734k |
Non-Current Assets | 1.3m |
PP&E | 1.3m |
Intangibles | 63k |
Current Liabilities | 2.7m |
Accounts Payable | 2.3m |
Other Current Liabilities | 334k |
Non-Current Liabilities | 3.1m |
Long-Term Debt | 541k |
Other Non-Current Liabilities | 2.6m |
Earnings Waterfall
Allmed Solutions Ltd
Revenue
|
0
ILS
|
Operating Expenses
|
-3.3m
ILS
|
Operating Income
|
-3.3m
ILS
|
Other Expenses
|
4.8m
ILS
|
Net Income
|
1.4m
ILS
|
Free Cash Flow Analysis
Allmed Solutions Ltd
ILS | |
Free Cash Flow | ILS |
ALMD Profitability Score
Profitability Due Diligence
Allmed Solutions Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
Score
Allmed Solutions Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
ALMD Solvency Score
Solvency Due Diligence
Allmed Solutions Ltd's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Score
Allmed Solutions Ltd's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ALMD Price Targets Summary
Allmed Solutions Ltd
Dividends
Current shareholder yield for ALMD is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Allmed Solutions Ltd. engages in the development, manufacture, and marketing of minimally invasive products internationally in various medical disciplines. Its products are used by physicians to treat a number of diseases and patients worldwide. The firm's product lines include: Covered Stents, which offers Ureteral Stent (URS), Round Posterior Stent (RPS), Triangular Prostatic Stent (TPS), Bulbar Stent (BUS) and Biliary Stent (BIS); Uro-Gynecology, which offers EndoFast Reliant System, EndoFast Resorb, EndoFast Reliant MN and EndoFast Reliant SCP; Type II Diabetes, which offers the Gastro-duodenal sleeve (GDS), as well as Cardiovascular, which offers WIRION EPD System. The firm's products serve patients with the following medical conditions: Pelvic Organ Prolapse (POP), Sacrocolpopexy, Male Stress Urinary Incontinence (SUI), Urethral/Ureteral Stricture, Carotid Stenosis, Biliary Stricture and Type II Diabetes.
Officers
The intrinsic value of one ALMD stock under the Base Case scenario is 53.19 ILS.
Compared to the current market price of 33.2 ILS, Allmed Solutions Ltd is Undervalued by 38%.